EHRA Premium Access

Survival analysis in patients with and without implantable cardioverter defibrillator for primary prevention indication: a single-centre multiethnic experience

Topic: Primary prevention (Sudden cardiac death and implantable defibrillators)

Congress Presentation

About the speaker

Miss Aye Ayemon

University Hospital Southampton, Southampton (United Kingdom of Great Britain & Northern Ireland)
0 follower

13 more presentations in this session

Which is the benefit of ICD in patients with ischemic cardiomyopathy compare with those with idiopathic dilated cardiomyopathy, from DANISH trial to real life.

Speaker: Doctor A. Tronconi (Buenos Aires, AR)


Validation of a madit-ii derived, primary prevention mortality risk score after implantable cardioverter-defibrillator implantation

Speaker: Doctor J. Acosta Martinez (Seville, ES)


Clinical outcomes after implantable cardioverter-defibrillator implantation: does gender matter? a propensity score analysis

Speaker: Doctor J. Acosta Martinez (Seville, ES)


Are implantable defibrillators less useful in patients with non-ischemic heart disease?

Speaker: Doctor A. Marinheiro (Setubal, PT)


Postextrasystolic blood pressure potentiation is associated with appropriate device therapy and mortality in implantable cardioverter defibrillator recipients with a reduced LVEF

Speaker: Miss A. van der Lingen (Amsterdam, NL)


Access the full session

Poster session 1 - Sudden cardiac death and implantable defibrillators

Speakers: Miss A. Ayemon, Doctor A. Tronconi, Doctor J. Acosta Martinez, Doctor J. Acosta Martinez, Doctor A. Marinheiro...

About the event



18 June - 21 June 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb